Management of Oesophageal and Gastric Cancers
Oesophageal cancer aetiologically, therapeutically and prognostically should be divided into two common histological types, rather than considered together, although many of the treatments overlap. Squamous cancers can affect the entire oesophagus, whereas adenocarcinomas are confined to the distal oesophagus and gastro-oesophageal junction. Most tumours present at stage T3 or greater and/or are node positive, and cure with multimodality therapy is only around 15 %.
KeywordsEarly Gastric Cancer Endoscopic Mucosal Resection Oesophageal Cancer Argon Plasma Coagulation Combine Modality Treatment
- 7.Ronellenfitsch U, Schwarzbach M, Hofheinz R, et al. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochrane Database Syst Rev. 2013;5:CD008107.Google Scholar
- 13.Wagner AD, Unverzagt S, Grothe W, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010;(3):CD004064.Google Scholar
- 18.Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97.CrossRefPubMedGoogle Scholar